20.82
price down icon3.07%   -0.66
after-market Handel nachbörslich: 20.85 0.03 +0.14%
loading

Immunome Inc Aktie (IMNM) Neueste Nachrichten

pulisher
Jan 01, 2026

Understanding the Setup: (IMNM) and Scalable Risk - Stock Traders Daily

Jan 01, 2026
pulisher
Dec 30, 2025

Top Executive Makes Bold Move With Fresh Immunome Stock Purchase - TipRanks

Dec 30, 2025
pulisher
Dec 30, 2025

Insider Buying: Clay Siegall Acquires Additional Shares of Immunome Inc (IMNM) - GuruFocus

Dec 30, 2025
pulisher
Dec 30, 2025

Immunome (NASDAQ:IMNM) CEO Purchases $100,018.35 in Stock - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Immunome (IMNM) CEO Siegall buys $100k in shares By Investing.com - Investing.com Nigeria

Dec 30, 2025
pulisher
Dec 30, 2025

Immunome (IMNM) CEO Siegall buys $100k in shares - Investing.com India

Dec 30, 2025
pulisher
Dec 30, 2025

Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Immunome (IMNM) - The Globe and Mail

Dec 30, 2025
pulisher
Dec 27, 2025

Why Immunome stock surged today - MSN

Dec 27, 2025
pulisher
Dec 25, 2025

Immunome (IMNM): Assessing Valuation After Strong Phase 3 Varegacestat Data and $400 Million Equity Raise - Sahm

Dec 25, 2025
pulisher
Dec 24, 2025

Immunome (IMNM) price target increased by 33.44% to 34.94 - MSN

Dec 24, 2025
pulisher
Dec 24, 2025

Immunome, a top 3% stock, just delivered a 'knockout' to Merck KGaA - MSN

Dec 24, 2025
pulisher
Dec 23, 2025

Immunome (NASDAQ:IMNM) Director Isaac Barchas Sells 383,200 Shares - MarketBeat

Dec 23, 2025
pulisher
Dec 23, 2025

Guggenheim reiterates Buy rating on Immunome stock following $400M financing By Investing.com - Investing.com South Africa

Dec 23, 2025
pulisher
Dec 23, 2025

Guggenheim reiterates Buy rating on Immunome stock following $400M financing - Investing.com Nigeria

Dec 23, 2025
pulisher
Dec 22, 2025

Insider Buying: Clay Siegall Acquires Additional Shares of Immun - GuruFocus

Dec 22, 2025
pulisher
Dec 22, 2025

Hedge Fund and Insider Trading News: Michael Hintze, Xavier Majic, Stanley Druckenmiller, Warren Buffett, Bill Ackman, Bridgewater Associates, Citadel Investment Group, Infini Capital, Immunome Inc (IMNM), White Mountains Insurance Group Ltd (WTM), a - Insider Monkey

Dec 22, 2025
pulisher
Dec 22, 2025

Siegall buys Immunome (IMNM) shares worth $149k By Investing.com - Investing.com Nigeria

Dec 22, 2025
pulisher
Dec 22, 2025

Immunome (NASDAQ:IMNM) Insider Purchases $204,900.00 in Stock - MarketBeat

Dec 22, 2025
pulisher
Dec 22, 2025

Siegall buys Immunome (IMNM) shares worth $149k - Investing.com India

Dec 22, 2025
pulisher
Dec 22, 2025

Tsai Philip buys $204,899 in Immunome stock By Investing.com - Investing.com South Africa

Dec 22, 2025
pulisher
Dec 22, 2025

Tsai Philip buys $204,899 in Immunome stock - Investing.com

Dec 22, 2025
pulisher
Dec 22, 2025

Immunome CTO Philip Tsai Buys 10,000 Shares - TradingView — Track All Markets

Dec 22, 2025
pulisher
Dec 20, 2025

Will Immunome Inc. stock see insider buyingMarket Growth Summary & Verified Swing Trading Watchlist - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Clay Siegall Bought 5.8% More Shares In Immunome - simplywall.st

Dec 20, 2025
pulisher
Dec 20, 2025

Immunome Chairman Acquires 5.8% More Stock - Yahoo Finance

Dec 20, 2025
pulisher
Dec 19, 2025

Aug Breakouts: Will Immunome Inc. stock see insider buyingWeekly Profit Report & Free AI Powered Buy and Sell Recommendations - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

How institutional buying supports Immunome Inc. stock2025 Biggest Moves & Fast Moving Stock Trade Plans - ulpravda.ru

Dec 19, 2025
pulisher
Dec 19, 2025

Immunome Inc. Stock (IMNM) Opinions on Phase 3 RINGSIDE Trial Results - Quiver Quantitative

Dec 19, 2025
pulisher
Dec 19, 2025

Is Immunome Inc. stock supported by strong fundamentalsPortfolio Return Report & Scalable Portfolio Growth Methods - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Can Immunome Inc. stock deliver strong Q4 earnings2025 Macro Impact & Low Volatility Stock Recommendations - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Immunome’s Varegacestat shows dramatic results in Phase 3 desmoid tumor trial - Indian Pharma Post

Dec 18, 2025
pulisher
Dec 18, 2025

Portfolio Recap: How institutional buying supports Immunome Inc. stockProduct Launch & AI Powered Buy/Sell Recommendations - ulpravda.ru

Dec 18, 2025
pulisher
Dec 18, 2025

Aug Breakouts: Why Immunome Inc. stock remains resilient2025 Geopolitical Influence & AI Driven Price Forecasts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Top Biotech Stocks To ConsiderDecember 15th - MarketBeat

Dec 18, 2025
pulisher
Dec 18, 2025

Insider Buying: Clay Siegall Acquires 46,511 Shares of Immunome Inc (IMNM) - GuruFocus

Dec 18, 2025
pulisher
Dec 18, 2025

Insider Buying: Immunome (NASDAQ:IMNM) CEO Acquires 46,511 Shares of Stock - MarketBeat

Dec 18, 2025
pulisher
Dec 18, 2025

Immunome Insider Bought Shares Worth $999,987, According to a Recent SEC Filing - marketscreener.com

Dec 18, 2025
pulisher
Dec 18, 2025

Immunome (IMNM) CEO and director buys shares in public offering - Stock Titan

Dec 18, 2025
pulisher
Dec 18, 2025

Can Immunome Inc. stock hit analyst price targets2025 Growth vs Value & Accurate Technical Buy Alerts - ulpravda.ru

Dec 18, 2025
pulisher
Dec 18, 2025

Latham & Watkins Advises on Immunome’s US$400 Million Public Offering - Legal Desire Media and Insights

Dec 18, 2025
pulisher
Dec 18, 2025

Lifesci Capital Has Pessimistic View of Immunome Q3 Earnings - MarketBeat

Dec 18, 2025
$38.86
price up icon 0.57%
$31.82
price up icon 3.31%
$101.42
price up icon 2.68%
$96.69
price up icon 1.57%
biotechnology ONC
$311.02
price up icon 2.37%
$177.12
price up icon 1.77%
Kapitalisierung:     |  Volumen (24h):